CHAPEL HILL, NC (October 7, 2020)- Devana Solutions, LLC is pleased to announce that the API-integration of Devana IGNITE with RealTime CTMS has been enhanced in support of both companies’ mutual customers. Devana IGNITE provides clinical research organizations is the leading cloud platform for pipeline administration, pre-clinical workflow automation and metrics capture and analytics. Devana IGNITE’s functionality is complementary to Real-Time CTMS, a leading provider of workflow automation including patient visit scheduling and related billing during the clinical phase of research studies.

In 2018, Rick Greenfield, CEO of Real-Time and Barry Lake, CEO of Devana Solutions, met at SCRS Site Solutions Summit to explore an integration of their solutions at the behest of mutual customers. “In our earliest days, many of the CTMS makers were skeptical of our intent behind developing Devana IGNITE” Lake explained, “we felt enough good CTMS solutions existed but platforms like Devana to facilitate study startup collaboration across functional groups and the capture and analysis of site performance metrics simply didn’t exist. I really credit Rick for being the first major CTMS maker to embrace an API-connection to reduce duplicate data entry and allow our mutual Real-Time and Devana customers to benefit from a seamless exchange of data from the system where it is best-captured.”

The backdrop driving this latest enhancement to the Real-Time CTMS – Devana IGNITE enhanced connectivity is the clinical trials industry at the site level continuing to consolidate. With research organizations growing and requiring more support from their trusted technology vendors, Devana Solutions and RealTime CTMS had their engineers improve their existing API-integration to function with Real-Time’s recently launched enterprise version supporting integrated site networks. The enhanced integration now expands across both companies’ entire product suite and is available to mutual customers and prospects of Real-Time and Devana Solutions. Both companies’ continued innovation will allow the clinical trials industry to more efficiently deliver advance therapies to patients.

Learn more about the Devana Solutions & RealTime CTMS integration here: https://devanasolutions.com/real-time/

About Devana Solutions, LLC:

Devana Solutions®, LLC is a cloud SaaS provider driven by a core belief that data transparency through technology is critical to selection of the top performing research sites to align with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease.

Devana Solutions® flagship platform, Devana IGNITE, allows integrated site networks and research organizations to standardize workflows, particularly in study startup, across site functions while allowing for the capture and display of performance metrics for dashboarding and analytics beyond site CTMS. Devana PROPEL extends performance data transparency across Academic Research Institutions or an expanded network of owned and affiliated investigative sites. Devana IQ allows for the sharing of performance data and documents in real-time between investigative site and Sponsor or CRO stakeholders. To learn more visit https://devanasolutions.com.

CHAPEL HILL, NC (SEPTEMBER 24, 2020)-Devana Solutions, LLC (Devana) is delighted to announce their newest client-partnership with the esteemed Rainier Clinical Research Center (Rainier), located about 15 minutes from downtown Seattle, Washington. The two companies connected when Rainier, a rapidly growing research organization, set out on a journey to find a technology that was able to provide the functionality needed to meet their metrics-focused needs. Once they were introduced to Devana, the journey was complete; they are now armed with the clinical research industry’s leading cloud-based technology to help them forge onward with their growth.

Rainier was founded in 1991 and began conducting research primarily in diabetes. In fact, Rainier has been involved in clinical research relating to all the major classes of diabetes drugs and devices over the past 30 years; quite a remarkable feat! Today, Rainier has expanded their therapeutic expertise beyond diabetes to a multi-therapeutic approach, including obesity, women’s health, and dermatology. With this therapeutic expansion, the need to increase their physical space arose, which brought them to the decision to recently expand into a 15,000 square foot facility, equipped with 11 overnight beds, a study participant recreation lounge, food prep kitchen and even an on-site gym for exercise testing. This new setup allows Rainier to continue their expansion into new therapeutic areas, while providing a comfortable setting for their patients.

Aside from needing a larger facility, Rainier also recognized the need for improved technology. They spent about six months using a very common CRM to manage their trial pipeline and startup activities but quickly realized they needed something better. Eric Hayashi, CEO of Rainier, said, “We became bogged down trying to customize our CRM to meet our needs, which was taking time away from our core competencies in executing clinical trials.” Hayashi, a veteran of four clinical outsourcing startups including LabConnect and Radiant Research over the past 29-years, knew that Rainier needed a technology already customized to meet the clinical research industry’s standards, as well as provide real-time transparency into study startup and performance metrics. Hayashi was very selective during his technology search and when he came across Devana, he knew he had found the best option for his metrics-focused research organization. “We were very thorough in our tech selection process and chose Devana because of the vast metrics they [Devana] provided, as well as their robust reporting and dashboarding capabilities,” said Hayashi.

Although 2020 may have been a tough year thus far, Rainier has not let it discourage them. They are more prepared than ever to take on any challenges that come their way and continue to focus on the most important part of research, the participants. Devana is humbled to partner with the forward-thinking minds at Rainier and look forward to a very successful collaboration.

About Rainier Clinical Research Center:

Rainier Clinical Research Center (RCRC), among the largest and most experienced dedicated clinical trial research sites in the country, has conducted more than 700 multi-specialty Phase I-IV medical device and biopharma clinical trials since 1991. To learn more visit https://rainier-research.com.

About Devana Solutions, LLC:

Devana Solutions®, LLC is a cloud SaaS provider driven by a core belief that data transparency through technology is critical to selection of the top performing research sites to align with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease.

Devana Solutions® flagship platform, Devana IGNITE, allows integrated site networks and research organizations to standardize workflows, particularly in study startup, across site functions while allowing for the capture and display of performance metrics for dashboarding and analytics beyond site CTMS. Devana PROPEL extends performance data transparency across Academic Research Institutions or an expanded network of owned and affiliated investigative sites. Devana IQ allows for the sharing of performance data and documents in real-time between investigative site and Sponsor or CRO stakeholders. To learn more visit https://devanasolutions.com.

Accel Clinical Services acquires Meridien Research site network, selected as location for Moderna COVID-19 vaccine trial.

CHAPEL HILL, NC (July 29, 2020) — Devana Solutions, LLC (Devana) is celebrating their partner-client’s, Accel Clinical Services (parent company to Accel Research Sites), recent acquisition of AMPLIFY’s esteemed Meridien Research site network, NeuroStudies destination research unit, and the InSearch site business development network. Equally celebratory, Accel Research Sites was also chosen as the only Central Florida location to conduct Moderna’s COVE Phase 3 Study in efforts to develop the first COVID-19 vaccine.

Accel, now armed with a team of over 100 researchers, specializing in multi-phase and multi-therapeutic research, is proof that forward-thinking and innovation is the key to success. It was that same forward-thinking that brought them to their decision to partner with Devana, utilizing Devana’s technology’s time-saving automation and powerful data to make their processes more efficient, better therapeutically align them with Sponsors and CROs, and ultimately land more of the right trial opportunities, some being very timely in the COVID-19 era.

“With our recent acquisition, we were able to more than double our size, adding jobs here in Florida and throughout the Southeast and expanding our trial footprint. We are very excited to serve as a site for several COVID-19 trials and have begun enrolling the first of thousands of participants in the Orlando, Florida area. This is a critical time in our industry and our world, and we are proud to be part of developing a vaccine,” said Matt Maxwell, CEO of Accel Research Sites.

Now, more than ever, clinical research organizations need a tool to strengthen their ability to manage the clinical trial process anywhere, anytime and at an efficient pace. Adaptability is what fuels growth in this industry. Devana continues to innovate to meet the needs of this everchanging industry and support research organizations, like Accel, that continue to move the needle and pave the way forward.

“Supporting high growth, tech-enabled research organizations is what Devana Solutions does best,” said Barry Lake, CEO, Devana Solutions, “Accel Research Sites under Matt’s leadership epitomizes high growth and tech-enabled.”

Devana’s support of Accel, especially as they help to develop a potential vaccine against COVID-19, brings their mission to life. The driving force behind this dynamic and disruptive tech company is knowing that their continuous innovations and enduring partnerships will, ultimately, help save lives. That is their motivation.

About Accel Clinical Services

Accel Clinical Services is a portfolio of companies dedicated to supporting independent physicians and their patients in the delivery of high-quality medical care. It serves as the parent company to subsidiaries built to align services around the needs of its customers: Accel Research Sites, Accel Trial Connections Network, Accel Patient Communities, Accel Provider Communities, and Accel Research Management.

About Accel Research Sites

Accel Research Sites is a multi-therapeutic network of clinical research sites dedicated to the expert delivery of treatment options to patients and providers. They partner with the most innovative and significant pharmaceutical, biotechnology, and medical device companies worldwide to advance healthcare and wellness in the communities they serve.

About Devana Solutions, LLC:

Devana Solutions®, LLC is a cloud SaaS provider driven by a core belief that data transparency through technology is critical to selection of the top performing research sites to align with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease.

Devana Solutions® flagship platform, Devana IGNITE, allows integrated site networks and research organizations to standardize workflows, particularly in study startup, across site functions while allowing for the capture and display of performance metrics for dashboarding and analytics beyond site CTMS. Devana PROPEL extends performance data transparency across Academic Research Institutions or an expanded network of owned and affiliated investigative sites. Devana IQ allows for the sharing of performance data and documents in real-time between investigative site and Sponsor or CRO stakeholders. To learn more visit https://devanasolutions.com.

Devana Solutions, LLC (Devana) is pleased to announce their newest client-partnership with Cedar Health Research, a rapidly growing research site network with two Dallas area sites and soon to be expanding throughout Texas and nationally. Cedar Health Research is a strong advocate for technological innovation in the clinical trial space. We are honored that such a proactive and innovative group has chosen Devana to help with their vision to set the gold standard for clinical trial execution.

Cedar’s mission is to “transform the clinical research domain through the effective adoption of innovative technologies in a research site network that produces data with integrity,” so when the initial conversations between Devana and Cedar began, we quickly realized the synergies, after all, data integrity is what Devana Solutions is all about! By partnering with Devana, Cedar will now have real-time transparency into their sites’ performance metrics, helping them to better align with their Sponsor and CRO partners, both therapeutically and operationally.

Aside from leveraging the powerful Devana IGNITE technology for successful trial execution, Cedar is also powered by Aspen Insights, a next-generation technology provider that is changing how researchers find trial patients through the application of artificial intelligence and machine learning. Sites and Sponsors often face several barriers when recruiting for clinical trials, no matter the indication. Slow and inaccurate candidate recruitment, lack of access to a qualified patient population and low physician-engaged recruitment can make finding qualified candidates unfeasible. Cedar Health Research is on a mission to change that by applying Aspen Insights’ artificial intelligence technology that delivers instantaneous, methodical and accurate patient-trial match results.

There is no doubt that Cedar Health Research is well on their way to making quite the impact on the clinical trials industry. The future of research is dependent on the hard work of research organizations like Cedar, as well as the technologies that empower them. Devana Solutions is delighted to stand alongside Cedar as they pave the way with their pioneering mentality.

ABOUT CEDAR HEALTH RESEARCH:

To learn more, visit https://www.cedarhealthresearch.com/. To learn more about Aspen Insights, visit https://aspeninsights.com/.

ABOUT DEVANA SOLUTIONS LLC:

Devana Solutions®, LLC is a cloud SaaS provider driven by a core belief that data transparency through technology is critical to selection of the top performing research sites to align with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease.

Devana Solutions® flagship platform, Devana IGNITE, allows integrated site networks and research organizations to standardize workflows, particularly in study startup, across site functions while allowing for the capture and display of performance metrics for dashboarding and analytics beyond site CTMS. Devana PROPEL extends performance data transparency across Academic Research Institutions or an expanded network of owned and affiliated investigative sites. Devana IQ allows for the sharing of performance data and documents in real-time between investigative site and Sponsor or CRO stakeholders. To learn more visit https://devanasolutions.com.

Devana Solutions is pleased to announce our newest client-partnership with Circuit Clinical, one of the largest Integrated Research Organizations in the United States! Devana Solutions continues to change the game for the industry’s leading research organizations, like Circuit Clinical, with its innovative and disruptive technologies.

Circuit Clinical understands the importance of the physician and patient relationship. Their core belief is that patients prefer to learn about clinical research from the healthcare providers they know and trust, thus the vision for Circuit Clinical emerged in 2015. The Circuit Clinical mission strives to transform the experience of how people find, choose and participate in clinical research. By partnering with physicians, Circuit Clinical gains direct access to interested and qualified patients, opening a door to more than 1-million patients that currently exist within their network. Combining this with their very own technology product, TrialScout^TM, a digital platform that allows patients to find, rate and review their clinical trial experiences, shines a light on a new path forward in clinical research.

Now, with the addition of Devana Solutions, LLC IGNITE cloud software, Circuit Clinical is on an even brighter path with the ability to simplify contact and account management, study start-up and execution, all while seamlessly capturing performance metrics for analytics and reporting for true operational transparency, better-aligning Circuit Clinical with their CRO and Sponsor partners to advance new therapies for the benefit of patients.

“I first met members of the Circuit Clinical team at the SCRS Oncology Summit in Austin, then met Irfan Khan, CEO at the SCOPE Summit a couple weeks later and was incredibly impressed with the people, their passion for research and drive to innovate,” commented Barry Lake, Devana Solutions, CEO “Circuit Clinical’s embrace of Devana IGNITE is a perfect fit with their mission.”

Devana Solutions is honored to have the Circuit Clinical team using their technology to advance medicine!

ABOUT CIRCUIT CLINICAL:

Founded with a vision to transform the participant experience in clinical research, Circuit Clinical, an Integrated Research Organization is comprised of more than 30 multi-specialty groups and 3 ACO’s and an National Cancer Institute with access to more than 1 million lives. Circuit conducts Phase II – Phase IV clinical trials with the top 20 pharmaceutical companies.

Circuit developed the award-winning platform, TrialScout which provides Clinical Research Sites with a powerful patient engagement and retention tool that builds their brand with patients and sponsors. TrialScout supports clinical trials using the first-ever patient experience ratings and reviews, generating unique monthly analytics to optimize Site operations.

In 2019, Circuit Clinical was selected as a winner of the 43North competition – an international event aimed at cultivating high growth and innovative companies. Circuit Clinical (TrialScout) was Runner Up at Disruptive Innovations to Advance Clinical Trials’ innovation competition, DPharm Idol Disrupt (Dpharm 2019). In 2020, Circuit Clinical (TrialScout) is a Participant Engagement Award Finalist at the Society for Clinical Operations Executives annual summit (SCOPE 2020).

ABOUT DEVANA SOLUTIONS LLC:

Devana Solutions®, LLC is a cloud SaaS provider driven by a core belief that data transparency through technology is critical to selection of the top performing research sites to align with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease.

Devana Solutions® flagship platform, Devana IGNITE, allows integrated site networks and research organizations to standardize workflows, particularly in study startup, across site functions while allowing for the capture and display of performance metrics for dashboarding and analytics beyond site CTMS. Devana PROPEL extends performance data transparency across Academic Research Institutions or an expanded network of owned and affiliated investigative sites. Devana IQ allows for the sharing of performance data and documents in real-time between investigative site and Sponsor or CRO stakeholders. To learn more visit https://devanasolutions.com.

As we continue to forge through the pandemic, most businesses in this industry have been forced to rethink their current business models. What will clinical trial sites look like now? Perhaps we will see a rise in virtual trials. Maybe we allow some of our employees to work remotely. Possibly a change to our sick policies. Whatever the changes we decide to make, one thing is certain, we must prepare now, since we have been shown that we are not immune to a global health crisis. At Devana Solutions, LLC, we are committed to supporting sites as they make their preparations.

One of our newest client-partners, Segal Trials, a network of six research sites specializing in Phase I-IV trials in Psychiatry and Women’s Health Disorders, has been adjusting their business operations in light of the pandemic. Along with new capabilities, including virtual and in-home visits, they have adopted new technologies to ensure sustainability in our changing industry. They have accomplished these changes without losing site of the community they serve by hosting several mental health and clinical trials awareness events in the month of May, with safety precautions in place, of course.

“Being able to support sites like Segal Trials in their efforts to adapt to this new reality is what Devana Solutions is all about. We hope that through the efficiency that our technology offers, sites are able to focus on what’s most important, the patients,” said Emily Wike, Director of Strategic Partnerships, Devana Solutions, LLC.

Bonnie Segal, President of Segal Trials, commented, “the pandemic made it very clear to us that we need to modify our business model to meet the needs of our evolving industry. Our new partnership with Devana Solutions will be a critical tool for us to make our vision become a reality.”

Although the world has been a bit grim as of late, we are nothing but optimistic for the future of the clinical research industry. Working with sites like Segal Trials, that have remained steadfast in their mission to advance medical research, despite many obstacles, is what gives us hope.

Check out Segal Trials newest capabilities along with their patient and staff centric initiatives here https://www.segaltrials.com/

About Devana Solutions, LLC

Devana Solutions, LLC is developer and provider of cloud-based SaaS technology driven by a core belief that data transparency through technology is critical to aligning the top performing research organizations at the investigative site level with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease. Devana offers technology to standardize operational workflows, particularly in study startup, across site functions while allowing for the automated capture, analysis and display of real time performance data across clinical trial industry stakeholders. For more information about Devana Solutions, LLC visit: www.DevanaSolutions.com.

May 5, 2020 – Medix, a national organization specialized in workforce solutions and recruiting skilled personnel, and Devana Solutions, the leading cloud-based provider of clinical trial automation technology, are offering a suite of services to support clinical site operations through all stages of the pandemic.

The organizations are partnering to offer 90-day subscription and training for Devana’s LITE platform, a remote study startup collaboration tool for small trial sites, along with six hours of Medix Clinical Trial Consulting services on topics such as Budget Review/Amendment, SOP Writing, Emergency Preparedness Plan, Site Culture Assessment and Site Organizational Design.

“The COVID-19 pandemic has been a whirlwind for our industry. Research sites went from being shut down as ‘non-essential’ businesses to being the only path to diagnosis, treatment and prevention of this virus.  The rapid pace of change we are experiencing now is the kick start this industry needed for safer and more efficient scientific innovation,” said Molly Downhour, Medix Clinical Research Strategy Executive. “We’re here to offer short- and long-term measures sites can put in place now in order to maintain the positive changes to clinical research operations that the pandemic has ignited.”

“Our industry has seen a massive expansion of remote work as clinical teams adapt to work in a post-pandemic world,” said Barry Lake, CEO and Co-Founder of Devana Solutions. “Embracing cloud solutions for workflow automation and metrics capture/analysis will be key to site success moving forward.”

About Medix

Medix provides workforce solutions to clients and creates opportunity for talent representing a variety of industries, including Clinical Research, Healthcare and Scientific. Medix has been featured as well as one of Staffing Industry Analysts’ “Largest Staffing Firms in the United States,” as well as one of the “Fastest Growing Staffing Firm in the United States.” Medix has also been ranked as one of the Best & Brightest Places to Work in the Nation for three years and in ClearlyRated’s 2020 “Best of Staffing” Talent Diamond and Client awards for providing constantly excellent service, further earning our reputation as an industry leader. For more information, call (866) 44-MEDIX or visit www.medixteam.com.

About Devana Solutions

Devana Solutions®, LLC is a cloud SaaS provider driven by a core belief that data transparency through technology is critical to selection of the top performing research sites to align with pharmaceutical Sponsors and CROs to reduce clinical trial cycle time and costs to deliver new therapies to patients. Devana Solutions offers three platforms, IGNITE, PROPEL and IQ for sponsors and CROs, to provide historical and real-time data capture, aggregation and display to drug development stakeholders. For more information call (877) DEVANA-2 or visit https://devanasolutions.com.

It has been quite an unusual couple of months during the first part of 2020 due to global pandemic, COVID-19, but Devana Solutions, LLC has proven to be more essential than ever, keeping sites and their employees connected throughout the study startup process. We are honored to be such a valuable asset to our client-partners in the clinical research industry, as they continue working hard to bring much needed therapies and vaccines to those who need them most.

One of our outstanding client-partners, working hard to make a difference in the clinical research industry, is Del Sol Research Management in Tucson, Arizona.  Del Sol focuses primarily on Gastrointestinal Disease, Hepatology, Internal Medicine, Women’s Health and Medical Device studies.  With two convenient locations and fifteen full-time employees, including a Recruitment Manager, it is Del Sol’s mission to increase clinical research awareness within their community. In addition to the usual advertising and outreach that most sites do to increase their participant-base, Del Sol takes their efforts a step further by engaging with local advocacy groups and physicians to bring free health screens to impoverished populations, while educating them on clinical research. “All of these collaborations with our medical peers in the community not only increase study awareness, but also allow Del Sol and our employees to give back to our local community, especially in the poorer areas of our metropolitan area. We, as a company, are very passionate about improving the health and providing health care access to the Tucson community,” said Wendy Hotz, President, Del Sol Research Management.

Del Sol’s Senior VP of Clinical Operations was interviewed recently on a local Spanish television station, addressing the growing interest in clinical research within the Tucson Hispanic community and providing answers to questions that research-naïve individuals may have. It is becoming increasingly known that the Hispanic population has a higher rate of Nonalcoholic Fatty Liver Disease than other ethnicities.  Since this disease can be silent for years before symptoms arise, the need for faster diagnosis is more important than ever, so patients can make the necessary lifestyle changes earlier to combat this deadly disease.  Thanks to their in-house Fibroscan®, Del Sol is able to quickly measure liver fibrosis and steatosis of their study participants, making Del Sol an asset to Sponsors and CROs on GI and Hepatic indication-related clinical trials.  In addition to the application of their Fibroscan®, Del Sol has developed expertise in a number of advanced procedures, including serial PK studies, complex infusions, endoscopy, colonoscopy, bile duct stent placement, flexible sigmoidoscopy, biopsy collection from various tissues, sample processing and specimen management,  pulmonary function testing and intrauterine procedures.

With their vast experience and dedication to their patients, staff and CRO/Sponsor relationships, it is no surprise that Del Sol’s excellent reputation precedes them.  We are humbled that they have chosen to partner with Devana Solutions, LLC to continue to revolutionize their clinical trial processes by leveraging our innovative technology platform.  We can’t wait to see what the rest of this year brings for Del Sol!

About Devana Solutions, LLC

Devana Solutions, LLC is developer and provider of cloud-based SaaS technology driven by a core belief that data transparency through technology is critical to aligning the top performing research organizations at the investigative site level with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease. Devana offers technology to standardize operational workflows, particularly in study startup, across site functions while allowing for the automated capture, analysis and display of real time performance data across clinical trial industry stakeholders. For more information about Devana Solutions, LLC visit: www.DevanaSolutions.com.

Devana Solutions, LLC is one of the clinical research industry’s most innovative technology companies serving and partnering with the industry’s leading research organizations. This week we’re pleased to announce and introduce our latest partner-client: hyperCORE International – the second largest clinical research site organization in the world!

hyperCORE International is a super network of highly experienced and awarded clinical research site/network companies. hyperCORE International unifies the clinical research industry’s most respected and advanced research site companies, facilitating a level of unparalleled collaboration. hyperCORE International is an industry leader providing Phase I-IV clinical trial services with more than 81 active research sites across the globe. Its member companies have completed more than 6,000 studies helping to evaluate thousands of new drugs and treatments in more than 15,000,000 patients. Each member operates as an independent company but, through the sharing of best practices, hyperCORE International accelerates every aspect of the research site process – from feasibility through study start-up and completion. Its members have won numerous awards for performance, quality and innovation.

hyperCORE International partner members leveraging Devana Solutions, LLC flagship easy-to-use Devana IGNITE cloud software to simplify contact and account management, study start-up and execution, while seamlessly capturing performance metrics for analytics and reporting include: AGA Clinical Trials of Hialeah, Florida; Benchmark Research of Austin, Texas; Clinical Site Partners of Miami, Florida; Clinical Trials of Texas of San Antonio, Texas; DIEX Recherche of Sherbrooke, Canada; IACT Health of Columbus, Georgia; and LMC Manna Research of Toronto, Canada.

In another milestone for Devana Solutions, LLC, these member networks will operate Devana IGNITE in tandem with Devana PROPEL for hyperCORE International providing an operating system to support collaboration across the super network.

The future of clinical research is here. Devana Solutions, LLC, powering better data, better decisions and better outcomes.  #clinicalresearch #clinicaltrials #data #metrics #innovativetechnology